« Back
2026 SITC EU Immuno-Oncology Summit
Sep 03 - Sep 04, 2026
Cedrik Britten, Chief Medical Officer, will give a presentation and participate in a panel discussion at the 2026 EU Immuno-Oncology Drug Development Summit in Lausanne.
Presentation
Date: September 3, 2026
Time: 9:35 – 9:55 AM CEST
Session: Session I: Beyond PD-1
Title: Clinical Development of TCR T-cell Therapies and Bispecific T cell Engagers Targeting PRAME+ Cancers
Panel Discussion
Date: September 3, 2026
Time: 9:55 – 10:25 AM CEST
Session: Session I: Beyond PD-1
For more information, visit the summit website by clicking here.
Location
Lausanne, Switzerland